Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen

被引：1

作者：

Lehner, F. ^{[1
]}

Sommerer, C. ^{[1
]}

Arns, W. ^{[1
]}

Reinke, P. ^{[1
]}

Eisenberger, U. ^{[1
]}

Wuthrich, R. ^{[1
]}

Pressmar, K. ^{[1
]}

Hauser, I. ^{[1
]}

Porstner, M. ^{[2
]}

May, C. ^{[2
]}

Paulus, E. ^{[2
]}

Muehlfeld, A. ^{[1
]}

Suwelack, B. ^{[1
]}

Wolters, H. ^{[1
]}

Witzke, O. ^{[1
]}

Stahl, R. ^{[1
]}

Budde, K. ^{[1
]}

机构：

[1] ZEUS Study Grp, Nurnberg, Germany

[2] Novartis Pharmaceut, Nueremberg, Germany

来源：

TRANSPLANTATION | 2014年 / 98卷

关键词：

D O I：

10.1097/00007890-201407151-02074

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

C1917

引用

页码：613 / 613

页数：1

共 50 条

[1] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: A POST HOC SUBGROUP ANALYSIS OF ZEUS
Lehner, F.
Budde, K.
Wuethrich, R. P.
Witzke, O.
Zeier, M.
Hauser, I. A.
Wolters, H. H.
Suwelack, B.
Heller, K.
Reinke, P.
Arns, W.
Stahl, R.
Muehlfeld, A.
Eisenberger, U.
Baeumer, D.
Porstner, M.
Sommerer, C.
[J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 24 - 24
[2] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
Lehner, F.
Sommerer, C.
Arns, W.
Reinke, P.
Eisenberger, U.
Wuthrich, R.
Pressmar, K.
Hauser, I.
Porstner, M.
May, C.
Paulus, E.
Muehlfeld, A.
Suwelack, B.
Wolters, H.
Witzke, O.
Stahl, R.
Budde, K.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 613 - 613
[3] POST HOC SUBGROUP ANALYSIS FROM ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN
Lehner, F.
Sommerer, C.
Arns, W.
Reinke, P.
Eisenberger, U.
Wuethrich, R. P.
Pressmar, K.
Porstner, M.
May, C.
Paulus, E. -M.
Muehlfeld, A.
Wolters, H. H.
Witzke, O.
Stahl, R. O.
Budde, K.
[J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 8 - 8
[4] Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data
Lehner, F.
Budde, K.
Wuethrich, R.
Reinke, P.
Arns, W.
Muehlfeld, A.
Eisenberger, U.
Stahl, R.
Heller, K.
Witzke, O.
Suwelack, B.
Wolters, H.
Hauser, I.
Porstner, M.
Sommerer, C.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[5] POST HOC SUBGROUP ANALYSIS OF ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: 5 YEAR FOLLOW-UP DATA
Lehner, F.
Budde, K.
Suwelack, B.
Arns, W.
Wuethrich, R. P.
Reinke, P.
Muehlfeld, A.
Eisenberger, U.
Stahl, R.
Porstner, M.
Heller, K.
Wolters, H. H.
Witzke, O.
Hauser, I. A.
Sommerer, C.
[J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 58 - 58
[6] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM CNI TO EVEROLIMUS-BASED REGIMEN: 5 YEAR DATA POST HOC ANALYSIS FROM THE ZEUS STUDY
Lehner, F.
Sommerer, C.
Arns, W.
Budde, K.
Wuethrich, R.
Reinke, P.
Muehlfeld, A.
Eisenberger, U.
Stahl, R.
Heller, K.
Suwelack, B.
Wolters, H.
Hauser, I.
Porstner, M.
Witzke, O.
[J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 242 - 243
[7] Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study
Lehner, Frank
Budde, Klemens
Zeier, Martin
Wuethrich, Rudolf P.
Reinke, Petra
Eisenberger, Ute
Muehlfeld, Anja
Arns, Wolfgang
Stahl, Rolf
Heller, Katharina
Witzke, Oliver
Wolters, Heiner H.
Suwelack, Barbara
Klehr, Hans Ulrich
Stangl, Manfred
Hauser, Ingeborg A.
Nadalin, Silvio
Porstner, Martina
May, Christoph
Paulus, Eva-Maria
Sommerer, Claudia
[J]. TRANSPLANT INTERNATIONAL, 2014, 27 (11) : 1192 - 1204
[8] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
Morales, J.
Fierro, A.
Benavente, D.
Zehnder, C.
Ferrario, M.
Contreras, L.
Herzog, C.
Buckel, E.
[J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
[9] EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR EXPOSURE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: EFFICACY, SAFETY AND RENAL FUNCTION OUTCOME FROM THE TRANSFORM STUDY
Sommerer, C.
Arns, W.
Weithofer, P.
Lehner, F.
Banas, B.
van der Giet, M.
Habicht, A.
Renders, L.
Rath, T.
Bartels, M.
Pratschke, J.
Hessel, K.
Bernhardt, P.
Witzke, O.
[J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 18 - 19
[10] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO LIVING RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: SUBGROUP ANALYSIS OF THE ZEUS STUDY
Lehner, F.
Arns, W.
Reinke, P.
Eisenberger, U.
Paulus, E. -M.
Scheidl, S.
Witzke, O.
Budde, K.
Sommerer, C.
[J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 51

← 1 2 3 4 5 →